kifunensine has been researched along with puromycin in 2 studies
Studies (kifunensine) | Trials (kifunensine) | Recent Studies (post-2010) (kifunensine) | Studies (puromycin) | Trials (puromycin) | Recent Studies (post-2010) (puromycin) |
---|---|---|---|---|---|
94 | 0 | 47 | 5,828 | 1 | 311 |
Protein | Taxonomy | kifunensine (IC50) | puromycin (IC50) |
---|---|---|---|
30S ribosomal protein S6 | Escherichia coli K-12 | 0.9 | |
30S ribosomal protein S7 | Escherichia coli K-12 | 0.9 | |
50S ribosomal protein L15 | Escherichia coli K-12 | 0.9 | |
50S ribosomal protein L10 | Escherichia coli K-12 | 0.9 | |
50S ribosomal protein L11 | Escherichia coli K-12 | 0.9 | |
50S ribosomal protein L7/L12 | Escherichia coli K-12 | 0.9 | |
50S ribosomal protein L19 | Escherichia coli K-12 | 0.9 | |
50S ribosomal protein L1 | Escherichia coli K-12 | 0.9 | |
50S ribosomal protein L20 | Escherichia coli K-12 | 0.9 | |
50S ribosomal protein L27 | Escherichia coli K-12 | 0.9 | |
50S ribosomal protein L28 | Escherichia coli K-12 | 0.9 | |
50S ribosomal protein L29 | Escherichia coli K-12 | 0.9 | |
50S ribosomal protein L31 | Escherichia coli K-12 | 0.9 | |
50S ribosomal protein L31 type B | Escherichia coli K-12 | 0.9 | |
50S ribosomal protein L32 | Escherichia coli K-12 | 0.9 | |
50S ribosomal protein L33 | Escherichia coli K-12 | 0.9 | |
50S ribosomal protein L34 | Escherichia coli K-12 | 0.9 | |
50S ribosomal protein L35 | Escherichia coli K-12 | 0.9 | |
50S ribosomal protein L36 | Escherichia coli K-12 | 0.9 | |
30S ribosomal protein S10 | Escherichia coli K-12 | 0.9 | |
30S ribosomal protein S11 | Escherichia coli K-12 | 0.9 | |
30S ribosomal protein S12 | Escherichia coli K-12 | 0.9 | |
30S ribosomal protein S13 | Escherichia coli K-12 | 0.9 | |
30S ribosomal protein S16 | Escherichia coli K-12 | 0.9 | |
30S ribosomal protein S18 | Escherichia coli K-12 | 0.9 | |
30S ribosomal protein S19 | Escherichia coli K-12 | 0.9 | |
30S ribosomal protein S20 | Escherichia coli K-12 | 0.9 | |
30S ribosomal protein S2 | Escherichia coli K-12 | 0.9 | |
30S ribosomal protein S3 | Escherichia coli K-12 | 0.9 | |
30S ribosomal protein S4 | Escherichia coli K-12 | 0.9 | |
30S ribosomal protein S5 | Escherichia coli K-12 | 0.9 | |
30S ribosomal protein S8 | Escherichia coli K-12 | 0.9 | |
30S ribosomal protein S9 | Escherichia coli K-12 | 0.9 | |
50S ribosomal protein L13 | Escherichia coli K-12 | 0.9 | |
50S ribosomal protein L14 | Escherichia coli K-12 | 0.9 | |
50S ribosomal protein L16 | Escherichia coli K-12 | 0.9 | |
50S ribosomal protein L23 | Escherichia coli K-12 | 0.9 | |
30S ribosomal protein S15 | Escherichia coli K-12 | 0.9 | |
50S ribosomal protein L17 | Escherichia coli K-12 | 0.9 | |
50S ribosomal protein L21 | Escherichia coli K-12 | 0.9 | |
50S ribosomal protein L30 | Escherichia coli K-12 | 0.9 | |
50S ribosomal protein L6 | Escherichia coli K-12 | 0.9 | |
30S ribosomal protein S14 | Escherichia coli K-12 | 0.9 | |
30S ribosomal protein S17 | Escherichia coli K-12 | 0.9 | |
30S ribosomal protein S1 | Escherichia coli K-12 | 0.9 | |
50S ribosomal protein L18 | Escherichia coli K-12 | 0.9 | |
Puromycin-sensitive aminopeptidase | Homo sapiens (human) | 6.075 | |
50S ribosomal protein L2 | Escherichia coli K-12 | 0.9 | |
50S ribosomal protein L3 | Escherichia coli K-12 | 0.9 | |
50S ribosomal protein L24 | Escherichia coli K-12 | 0.9 | |
50S ribosomal protein L4 | Escherichia coli K-12 | 0.9 | |
50S ribosomal protein L22 | Escherichia coli K-12 | 0.9 | |
50S ribosomal protein L5 | Escherichia coli K-12 | 0.9 | |
30S ribosomal protein S21 | Escherichia coli K-12 | 0.9 | |
50S ribosomal protein L25 | Escherichia coli K-12 | 0.9 | |
50S ribosomal protein L36 2 | Escherichia coli K-12 | 0.9 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hara, K; Koide, T; Tokunaga, F | 1 |
Gregers, TF; Sandvig, K; Slominska-Wojewodzka, M; Wälchli, S | 1 |
2 other study(ies) available for kifunensine and puromycin
Article | Year |
---|---|
N-linked oligosaccharide processing, but not association with calnexin/calreticulin is highly correlated with endoplasmic reticulum-associated degradation of antithrombin Glu313-deleted mutant.
Topics: 1-Deoxynojirimycin; Alkaloids; Animals; Antithrombins; Calnexin; Calreticulin; Carbohydrate Conformation; Cells, Cultured; Cricetinae; Cycloheximide; Endoplasmic Reticulum; Enzyme Inhibitors; Glucosidases; Indolizines; Mannose; Mannosidases; Mutation; Oligosaccharides; Protein Synthesis Inhibitors; Protein Tyrosine Phosphatases; Puromycin | 2003 |
EDEM is involved in retrotranslocation of ricin from the endoplasmic reticulum to the cytosol.
Topics: Alkaloids; Animals; Cells, Cultured; Cytosol; Endoplasmic Reticulum; Enzyme Inhibitors; Humans; Immunoprecipitation; Membrane Proteins; Mice; Neoplasm Proteins; Protein Folding; Protein Transport; Puromycin; Ricin; RNA Interference; SEC Translocation Channels; Transcriptional Activation | 2006 |